Dyne Therapeutics (DYN) Submits IND to FDA for DMD Candidate

Dyne Therapeutics (DYN) files an investigational new drug application in the United States for a clinical study on its investigational candidate DYNE-251 to address Duchenne Muscular Dystrophy.